Literature DB >> 25994606

[Acute pain therapy in German hospitals as competitive factor. Do competition, ownership and case severity influence the practice of acute pain therapy?].

J Erlenwein1, J Hinz, W Meißner, U Stamer, M Bauer, F Petzke.   

Abstract

BACKGROUND: Due to the implementation of the diagnosis-related groups (DRG) system, the competitive pressure on German hospitals increased. In this context it has been shown that acute pain management offers economic benefits for hospitals. The aim of this study was to analyze the impact of the competitive situation, the ownership and the economic resources required on structures and processes for acute pain management.
MATERIAL AND METHODS: A standardized questionnaire on structures and processes of acute pain management was mailed to the 885 directors of German departments of anesthesiology listed as members of the German Society of Anesthesiology and Intensive Care Medicine (DGAI, Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin).
RESULTS: For most hospitals a strong regional competition existed; however, this parameter affected neither the implementation of structures nor the recommended treatment processes for pain therapy. In contrast, a clear preference for hospitals in private ownership to use the benchmarking tool QUIPS (quality improvement in postoperative pain therapy) was found. These hospitals also presented information on coping with the management of pain in the corporate clinic mission statement more often and published information about the quality of acute pain management in the quality reports more frequently. No differences were found between hospitals with different forms of ownership in the implementation of acute pain services, quality circles, expert standard pain management and the implementation of recommended processes. Hospitals with a higher case mix index (CMI) had a certified acute pain management more often. The corporate mission statement of these hospitals also contained information on how to cope with pain, presentation of the quality of pain management in the quality report, implementation of quality circles and the implementation of the expert standard pain management more frequently. There were no differences in the frequency of using the benchmarking tool QUIPS or the implementation of recommended treatment processes with respect to the CMI.
CONCLUSION: In this survey no effect of the competitive situation of hospitals on acute pain management could be demonstrated. Private ownership and a higher CMI were more often associated with structures of acute pain management which were publicly accessible in terms of hospital marketing.

Entities:  

Mesh:

Year:  2015        PMID: 25994606     DOI: 10.1007/s00482-015-0002-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  18 in total

Review 1.  [Regional anaesthesia as advantage in competition between hospitals. Strategic market analysis].

Authors:  A R Heller; K R Bauer; M Eberlein-Gonska; D M Albrecht; T Koch
Journal:  Anaesthesist       Date:  2009-05       Impact factor: 1.041

2.  [Postoperative pain relief is an important factor for the patients' selection of a clinic. Results of an anonymous survey].

Authors:  C Simanski; R Lefering; T Paffrath; P Riess; N Yücel; M Maegele; C Thüsing; E Neugebauer
Journal:  Schmerz       Date:  2006-08       Impact factor: 1.107

3.  [Inpatient acute pain management in German hospitals: results from the national survey "Akutschmerzzensus 2012"].

Authors:  J Erlenwein; U Stamer; R Koschwitz; W Koppert; M Quintel; W Meißner; F Petzke
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

4.  [Evaluation of the "initiative pain-free clinic" for quality improvement in postoperative pain management. A prospective controlled study].

Authors:  D Lehmkuhl; W Meissner; E A M Neugebauer
Journal:  Schmerz       Date:  2011-09       Impact factor: 1.107

5.  The quality of pain management in German hospitals.

Authors:  Christoph Maier; Nadja Nestler; Helmut Richter; Winfried Hardinghaus; Esther Pogatzki-Zahn; Michael Zenz; Jürgen Osterbrink
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

6.  [Impact of thoracic epidural analgesia on revenue for G-DRG M01B, OPS-301 5-604.0 (radical retropubic prostatectomy)].

Authors:  A R Heller; R J Litz; D Wiessner; C Dammann; R Weissgerber; O W Hakenberg; M P Wirth; T Koch
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

7.  Differences in the implementation of diagnosis-related groups across clinical departments: a German hospital case study.

Authors:  Hans-Gerd Ridder; Vanessa Doege; Susanne Martini
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

8.  [Quality management during postoperative pain therapy].

Authors:  B Geissler; E Neugebauer; R Angster; J Witte Dagger
Journal:  Chirurg       Date:  2004-07       Impact factor: 0.955

9.  Organization of acute pain services: a low-cost model.

Authors:  Narinder Rawal; Lars Berggren
Journal:  Pain       Date:  1994-04       Impact factor: 6.961

10.  [Postoperative pain therapy in Germany].

Authors:  U Stamer; N Mpasios; F Stüber; H Laubenthal; C Maier
Journal:  Anaesthesist       Date:  2002-04       Impact factor: 1.041

View more
  3 in total

1.  [Nursing pain experts in German hospitals : A compilation of activity profiles and tasks].

Authors:  R Boche; N Nestler; J Erlenwein; E Pogatzki-Zahn
Journal:  Schmerz       Date:  2018-02       Impact factor: 1.107

2.  [Role of anesthesiology in pain medicine and palliative care treatment in German hospitals : Survey of department heads of anesthesiology on treatment structures].

Authors:  J Erlenwein; F Petzke; U Stamer; W Meißner; F Nauck; E Pogatzki-Zahn; W Koppert; C Maier
Journal:  Anaesthesist       Date:  2017-04-26       Impact factor: 1.041

3.  The Quality of Postoperative Pain Therapy in German Hospitals.

Authors:  Winfried Meißner; Marcus Komann; Joachim Erlenwein; Ulrike Stamer; André Scherag
Journal:  Dtsch Arztebl Int       Date:  2017-03-10       Impact factor: 5.594

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.